Literature DB >> 2501353

Phenotypic characteristics of Branhamella catarrhalis strains.

J L Soto-Hernandez1, S Holtsclaw-Berk, L M Harvill, S L Berk.   

Abstract

Isolates of Branhamella catarrhalis from 13 patients with pneumonia, 6 patients with tracheobronchitis, and 8 patients who were colonized with the organism were studied with respect to susceptibility to the bactericidal action of normal human serum (NHS), glass slide hemagglutination (HA) of group O human erythrocytes, beta-lactamase production, and susceptibility to selected antimicrobial agents and laboratory drugs. A total of 18 of 27 isolates were serum resistant, 22 of 27 produced HA, and 21 of 27 were beta-lactamase positive. Statistically significant correlations were found between susceptibility to NHS and susceptibility to trypsin (r = +0.47; P = 0.01) and between susceptibility to NHS and HA (r = -0.48; P = 0.009). Significant correlations were also observed among several pairs of antimicrobial drugs. Analysis of variance showed that mean ampicillin MICs correlated with isolate group (r = -0.49; P = 0.03) in that the pneumonia isolates had higher MICs. Some phenotypic characteristics appeared to be independent of each other. These data suggest that important differences exist among clinically significant B. catarrhalis strains and that these differences may be due to differences in the cell wall envelope of the organism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501353      PMCID: PMC267452          DOI: 10.1128/jcm.27.5.903-908.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae.

Authors:  M A Apicella; M A Westerink; S A Morse; H Schneider; P A Rice; J M Griffiss
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

2.  Studies on gonococcus infection. XIII. Occurrence of color/opacity colonial variants in clinical cultures.

Authors:  J F James; J Swanson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae.

Authors:  M J Maness; P F Sparling
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

4.  In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

Authors:  S Alvarez; M Jones; S Holtsclaw-Berk; J Guarderas; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 5.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

6.  Effects of proteolytic enzymes on the outer membrane proteins of Neisseria gonorrhoeae.

Authors:  M S Blake; E C Gotschlich; J Swanson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

7.  Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association.

Authors:  L A Diamond; B Lorber
Journal:  Am Rev Respir Dis       Date:  1984-05

8.  Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

Authors:  G V Doern; S A Morse
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

9.  Development of bactericidal antibody during Branhamella catarrhalis infection.

Authors:  A J Chapman; D M Musher; S Jonsson; J E Clarridge; R J Wallace
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.

Authors:  T F Patterson; J E Patterson; B L Masecar; G E Barden; W J Hierholzer; M J Zervos
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

View more
  14 in total

1.  Epidemiological typing of Moraxella catarrhalis by pulsed field gel electrophoresis.

Authors:  S M Davison; D E Low; R H Cruz; D Beaulieu; S R Scriver
Journal:  Can J Infect Dis       Date:  1995-05

2.  Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

Authors:  C M Verduin; C Hol; E Van Dijke; J A Faber; M Jansze; J Verhoef; H Van Dijk
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

Authors:  C M Verduin; M Jansze; C Hol; T E Mollnes; J Verhoef; H van Dijk
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Epidemiological typing of Moraxella catarrhalis by using DNA probes.

Authors:  D Beaulieu; S Scriver; M G Bergeron; D E Low; T R Parr; J E Patterson; A Matlow; P H Roy
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

7.  Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.

Authors:  Ahmed S Attia; Sanjay Ram; Peter A Rice; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

8.  Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

Authors:  J Sarwar; A A Campagnari; C Kirkham; T F Murphy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection.

Authors:  M G Morgan; H McKenzie; M C Enright; M Bain; F X Emmanuel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

10.  Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis.

Authors:  Ahmed S Attia; Jennifer L Sedillo; Todd C Hoopman; Wei Liu; Lixia Liu; Chad A Brautigam; Eric J Hansen
Journal:  BMC Microbiol       Date:  2009-09-25       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.